In a recent American Bankruptcy Institute Journal article, Akerman Bankruptcy and Reorganization Chair Andrea Hartley and Partner John Thompson examined the Second Circuit’s opinion in Purdue Pharma III, the largest and most publicized case to come out of the opioid epidemic. The pair analyzed the circuit split over the permissibility of non-debtor third-party releases, the potential for U.S. Supreme Court review, possible legislative responses to the decision, and how public sentiment to the decision might evolve in its wake.